Home Medical stocks Medical & Biological Laboratories (TYO:4557) Shareholders Booked A 32% Gain In The...

Medical & Biological Laboratories (TYO:4557) Shareholders Booked A 32% Gain In The Last Three Years – Simply Wall St News

42
0

One simple way to benefit from the stock market is to buy an index fund. But many of us dare to dream of bigger returns, and build a portfolio ourselves. Just take a look at Medical & Biological Laboratories Co., Ltd. (TYO:4557), which is up 32%, over three years, soundly beating the market decline of 1.3% (not including dividends). However, more recent returns haven’t been as impressive as that, with the stock returning just 22% in the last year.

See our latest analysis for Medical & Biological Laboratories

To quote Buffett, ‘Ships will sail around the world but the Flat Earth Society will flourish. There will continue to be wide discrepancies between price and value in the marketplace…’ One flawed but reasonable way to assess how sentiment around a company has changed is to compare the earnings per share (EPS) with the share price.

During three years of share price growth, Medical & Biological Laboratories achieved compound earnings per share growth of 221% per year. The average annual share price increase of 9.6% is actually lower than the EPS growth. Therefore, it seems the market has moderated its expectations for growth, somewhat.

You can see below how EPS has changed over time (discover the exact values by clicking on the image).

earnings-per-share-growth
JASDAQ:4557 Earnings Per Share Growth September 29th 2020

It might be well worthwhile taking a look at our free report on Medical & Biological Laboratories’ earnings, revenue and cash flow.

A Different Perspective

It’s nice to see that Medical & Biological Laboratories shareholders have received a total shareholder return of 22% over the last year. That’s better than the annualised return of 2.3% over half a decade, implying that the company is doing better recently. Given the share price momentum remains strong, it might be worth taking a closer look at the stock, lest you miss an opportunity. Before deciding if you like the current share price, check how Medical & Biological Laboratories scores on these 3 valuation metrics.

If you like to buy stocks alongside management, then you might just love this free list of companies. (Hint: insiders have been buying them).

Please note, the market returns quoted in this article reflect the market weighted average returns of stocks that currently trade on JP exchanges.

Promoted
When trading Medical & Biological Laboratories or any other investment, use the platform considered by many to be the Professional’s Gateway to the Worlds Market, Interactive Brokers. You get the lowest-cost* trading on stocks, options, futures, forex, bonds and funds worldwide from a single integrated account.

This article by Simply Wall St is general in nature. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
*Interactive Brokers Rated Lowest Cost Broker by StockBrokers.com Annual Online Review 2020

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected].

https://simplywall.st/stocks/jp/pharmaceuticals-biotech/jasdaq-4557/medical-biological-laboratories-shares/news/medical-biological-laboratories-tyo4557-shareholders-booked-a-32-gain-in-the-last-three-years/
https://simplywall.st/stocks/jp/pharmaceuticals-biotech/jasdaq-4557/medical-biological-laboratories-shares/news/medical-biological-laboratories-tyo4557-shareholders-booked-a-32-gain-in-the-last-three-years/

This site uses Akismet to reduce spam. Learn how your comment data is processed.